Isracann Biosciences Inc (ISCNF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Isracann Biosciences Net Income (TTM): -3.574M for Aug. 31, 2022
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| August 31, 2022 | -3.574M |
| May 31, 2022 | -3.705M |
| February 28, 2022 | -19.22M |
| November 30, 2021 | -20.04M |
| August 31, 2021 | -20.36M |
| May 31, 2021 | -20.16M |
| February 28, 2021 | -13.68M |
| November 30, 2020 | -16.13M |
| August 31, 2020 | -17.07M |
| May 31, 2020 | -17.65M |
| February 29, 2020 | -6.446M |
| November 30, 2019 | -3.481M |
| August 31, 2019 | -3.924M |
| May 31, 2019 | -7.314M |
| February 28, 2019 | -8.773M |
| November 30, 2018 | -11.09M |
| August 31, 2018 | -10.13M |
| May 31, 2018 | -6.089M |
| February 28, 2018 | -4.743M |
| November 30, 2017 | -1.775M |
| August 31, 2017 | -0.4468M |
| May 31, 2017 | -0.5065M |
| February 28, 2017 | -0.5215M |
| Date | Value |
|---|---|
| November 30, 2016 | -0.4597M |
| August 31, 2016 | -0.4541M |
| May 31, 2016 | -0.3687M |
| February 29, 2016 | -0.3326M |
| November 30, 2015 | -0.3501M |
| August 31, 2015 | -0.4954M |
| May 31, 2015 | -0.5183M |
| February 28, 2015 | -0.4966M |
| November 30, 2014 | -0.4104M |
| August 31, 2014 | -0.1802M |
| May 31, 2014 | -0.0954M |
| February 28, 2014 | -0.0807M |
| November 30, 2013 | -0.0831M |
| August 31, 2013 | -0.0813M |
| May 31, 2013 | -0.0983M |
| February 28, 2013 | -0.0967M |
| November 30, 2012 | -0.0963M |
| August 31, 2012 | -0.1038M |
| May 31, 2012 | -0.0714M |
| February 29, 2012 | -0.0729M |
| November 30, 2011 | -0.0733M |
| August 31, 2011 | -0.1233M |
| May 31, 2011 | -0.1374M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-20.36M
Minimum
Aug 2021
-3.481M
Maximum
Nov 2019
-12.34M
Average
-14.90M
Median
Net Income (TTM) Benchmarks
| Acasti Pharma Inc | -38.77M |
| Aurinia Pharmaceuticals Inc | -78.02M |
| Edesa Biotech Inc | -7.718M |
| Lexaria Bioscience Corp | -5.440M |
| Liminal Biosciences Inc (DELISTED) | 0.9031M |